A Multi-Center, Randomized Phase 3 Study of Adjuvant Oncophage vs. Observation in Patients with High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma

Grants and Contracts Details

StatusFinished
Effective start/end date10/28/054/30/08

Funding

  • Antigenics: $10,920.00